share_log

普利制药(300630.SZ):合成生物学方向公司目前积累的品种有依克多因、司美格鲁肽、红景天苷等

Puli Pharmaceuticals (300630.SZ): Synthetic biology companies currently accumulate varieties such as ecdoine, simeglutide, rhododendine, etc.

Gelonghui Finance ·  Mar 13 04:25

Gelonghui March 13 丨 An investor asked Puli Pharmaceuticals (300630.SZ) on the investor interactive platform, “What synthetic biology products does the company have?” The company replied that the varieties currently accumulated by the company in the field of synthetic biology include ecdoine, simeglutide, rhododendine, etc. Other projects under development are also continuing, and the company will continue to accumulate products in the field of synthetic biology in the future. For details, please refer to the relevant information disclosed in the periodic report.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment